Thursday, October 21, 2021

The overall puzzle of criminal culpability

"Unholy Trinity: Medicine, Science, and Corporate Power" (Mickey Z.).

"Why the Mainstream Media Remains Silent on the JFK Records Deadline" (Hornberger):

"I predict that within the next weeks, President Biden will grant a request by the CIA for continued secrecy of its assassination-related records. I predict that Biden will order the release of some of the records for appearance’s sake, but he will cite “national security” to justify continuing the secrecy of the vast majority of the records.

Why do I make this prediction? Because the reason that the CIA needed to keep these records secret 60 years ago still exists. That same reason was why it it needed to keep them secret during the 1990s, when the Assassination Records Review Board was enforcing the JFK Records Act of 1992, which mandated the release of all federal records relating to the assassination.

Further, that same reason obviously caused the CIA, despite the law’s mandate, to continue keeping its records secret for another 25 years after the JFK Records Act was enacted. When that deadline came due in 2017, that same reason obviously motivated the CIA to petition President Trump for another extension of time for secrecy, which Trump dutifully granted. That deadline comes due on October 26, 2021 — two weeks from now — and mark my words: The same reason will cause the CIA to request that Biden grant another extension of time for secrecy, which Biden, like Trump, will dutifully grant.

What is the reason that has caused the CIA to want to keep these thousands of records secret from the American people. The reason, I am more convinced than ever, is that the CIA knows that those remaining records constitute more pieces to the overall puzzle of criminal culpability on the part of the CIA in the regime-change operation that took place on November 22,1963."

"It All Makes Sense Once You Realize They Want to Kill Us" (Whitney):
"Have you ever wondered how the drug companies were able to roll out their own-individual vaccines just weeks apart from each other? That’s a pretty good trick, don’t you think; especially since vaccine development typically takes from 10 to 15 years. How do you think they managed that? Here’s an excerpt from an article which provides a little background on the topic:
“The virus behind the outbreak that began in Wuhan, China, was identified on Jan. 7. Less than a week later — on Jan. 13 — researchers at Moderna and the NIH had a proposed sequence for an mRNA vaccine against it, and, as the company wrote in government documents, “we mobilized toward clinical manufacture.” By Feb. 24, the team was shipping vials from a plant in Norwood, Mass., to the National Institute of Allergy and Infectious Diseases, in Bethesda, Md., for a planned clinical trial to test its safety.” (“Researchers rush to test coronavirus vaccine in people without knowing how well it works in animals”, Stat)
Got that? “The virus broke out in Wuhan…on Jan. 7, and less than a week later Moderna had a proposed sequence for an mRNA vaccine against it???

Really? Is that the same Moderna that had been playing-around with mRNA for over a decade but was never able to successfully bring a vaccine to market?

Yep, the very same company. Here’s more:

“And by Feb. 24, the team was shipping vials from a plant in Norwood, Mass??”

Wow! Another Covid miracle! You almost get whiplash watching these companies crank out their “wonder drugs” at record-breaking speed.

Keep in mind, there’s a very high probability that the virus was man-made, (In other words, it’s a bioweapon.) and the people who have been implicated in the funding and creation of that bioweapon are also closely aligned with the big drug companies that have produced the antidote in record time that has already netted tens of billions of dollars in profits for a drug for which there was no reliable animal testing, no long-term safety data, and no formal regulatory approval."
"Moderna: A Company “In Need Of A Hail Mary”" (Webb):
"Not only did the COVID-19 crisis obliterate hurdles that had previously prevented Moderna from taking a single product to market, it also dramatically reversed the company’s fortunes. Indeed, from 2016 right up until the emergence of COVID-19, Moderna could barely hold it together, as it was shedding key executives, top talent, and major investors at an alarming rate. Essentially, Moderna’s promise of “revolutionizing” medicine and the remarkable salesmanship and fund-raising capabilities of the company’s top executive, Stéphane Bancel, were the main forces keeping it afloat. In the years leading up to the COVID-19 crisis, Moderna’s promises—despite Bancel’s efforts—rang increasingly hollow, as the company’s long-standing penchant for extreme secrecy meant that—despite nearly a decade in business—it had never been able to definitively prove that it could deliver the “revolution” it had continually assured investors was right around the corner. 

This was compounded by major issues with patents held by a hostile competitor that threatened Moderna’s ability to turn a profit on anything it might manage to take to market, as well as major issues with its mRNA delivery system that led them to abandon any treatment that would require more than one dose because of toxicity concerns. The latter issue, though largely forgotten and/or ignored by media today, should be a major topic in the COVID-19 booster debate, given that there is still no evidence that Moderna ever resolved the toxicity issue that arose in multi-dose products.

In this first installment of a two-part series, the dire situation in which Moderna found itself immediately prior to the emergence of COVID-19 is discussed in detail, revealing that Moderna—very much like the now disgraced company Theranos—had long been a house of cards with sky-high valuations completely disconnected from reality. Part 2 will explore how that reality would have come crashing down sometime in 2020 or 2021 were it not for the advent of the COVID-19 crisis and Moderna’s subsequent partnership with the US government and the highly unusual processes involving its vaccine’s development and approval. Despite the emergence of real-world data challenging the claims that Moderna’s COVID-19 vaccine is safe and effective, Moderna’s booster is being rushed through by some governments, while others have recently banned the vaccine’s use in young adults and teens due to safety concerns. 

As this two-part series will show, safety concerns about Moderna were known well before the COVID crisis, yet they have been ignored by health authorities and the media during the crisis itself. In addition, in order to stave off collapse, Moderna must keep selling its COVID-19 vaccine for years to come. In other words, without the approval of its booster, which has caused great controversy even among the country’s top vaccine officials, Moderna faces a massive financial reckoning. While the COVID-19 crisis threw the company a lifeboat, the administration of its COVID-19 vaccine, in which the US government has now invested nearly $6 billion, must continue into the foreseeable future for the bailout to be truly successful. Otherwise, a company now worth $126.7 billion, with major investments from the US government, US military, and ties to the world’s wealthiest individuals, will crumble in short order."
and:
". . . at the 2019 Milken Institute Future of Health Summit, there was a panel discussion on universal flu vaccines and how a “disruptive” event would be needed to upset the long-existing bureaucratic vaccine-approval process to facilitate wider adoption of “nontraditional” vaccines, such as those produced by Moderna. Panel speakers including former FDA commissioner Margaret Hamburg, a veteran of the 2001 Dark Winter exercise and scientific advisor to the Gates foundation, as well as Anthony Fauci of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Rick Bright of BARDA, who previously worked for the Gates-funded PATH. The panel discussion notably took place shortly after the controversial coronavirus pandemic simulation called Event 201, whose moderators and sponsors had been intimately involved in 2001’s Dark Winter. 

During the panel, the moderator—Michael Specter of the New Yorker—asked the question: “Why don’t we blow the system up? Obviously, we just can’t turn off the spigot on the system we have and then say ‘Hey! everyone in the world should get this new vaccine we haven’t given to anyone yet,’ but there must be some way.” Specter then mentioned how vaccine production is antiquated and asked how sufficient “disruption” could occur to prompt the modernization of the existing vaccination development and approval process. Hamburg responded first, saying that as a society we are behind where we need to be when it comes to moving toward a new, more technological approach and that it is now “time to act” to make that a reality. 

Several minutes later, Anthony Fauci stated that the superior method of vaccine production involves “not growing the virus at all, but getting sequences, getting the appropriate protein and it sticking in on self-assembling nanoparticles,” essentially referring to mRNA vaccines. Fauci then stated: “The critical challenge . . . is that in order to make the transition from getting out of the tried and true egg-growing [method] . . . to something that has to be much better, you have to prove that this works and then you have got to go through all of the critical trials—phase 1, phase 2, phase 3—and show that this particular product is going to be good over a period of years. That alone, if it works perfectly, is going to take a decade.” Fauci later stated that there is a need to alter the public’s perception that the flu is not a serious disease in order to increase urgency and that it would be “difficult” to alter that perception along with the existing vaccine development and approval process unless the existing system takes the posture that “I don’t care what your perception is, we’re going to address the problem in a disruptive way and an iterative way.” 

During the panel, Bright stated that “we need to move as quickly as possible and urgently as possible to get these technologies that address speed and effectiveness of the vaccine” before discussing how the White House Council of Economic Advisers had just issued a report emphasizing that prioritizing “fast” vaccines was paramount. Bright then added that a “mediocre and fast” vaccine was better than a “mediocre and slow” vaccine. He then said that we can make “better vaccines and make them faster” and that urgency and disruption were necessary to produce the targeted and accelerated development of one such vaccine. Later in the panel, Bright said the best way to “disrupt” the vaccine field in favor of “faster” vaccines would be the emergence of “an entity of excitement out there that’s completely disruptive, that’s not beholden to bureaucratic strings and processes.” He later very directly said that by “faster” vaccines he meant mRNA vaccines. 

The Bright-led BARDA and the Fauci-led NIAID in just a few months’ time became the biggest backers of the Moderna COVID-19 vaccine, investing billions and co-developing the vaccine with the company, respectively. As will be explained in Part II of this series, the partnership between Moderna and the NIH to co-develop what would soon become Moderna’s COVID-19 vaccine was being forged as early as January 7, 2020, long before the official declaration of the COVID-19 crisis as a pandemic and before a vaccine was proclaimed as necessary by officials and other individuals. Not only did the COVID-19 vaccine quickly become the answer to nearly all Moderna’s woes but it also provided the disruptive scenario necessary to alter the public’s perceptions of what a vaccine is and eliminate existing safeguards and bureaucracy in vaccine approval."
"The Latest Spy Story: Was It Involving Israel Yet Again?" (Giraldi). I thought exactly the same thing when the government was described as a friend but no name was produced. Giraldi is wrong in saying Israel has no use for this info - as they have done before, they will turn around and sell it to the Chinese (or trade it for Silk Road favors).
blog comments powered by Disqus